PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CORONAVIRUS DISEASE 19, CONTAINING CARBOCYCLIC NUCLEOSIDE DERIVATIVE
The present invention relates to a pharmaceutical composition for prevention or treatment of coronavirus disease 19 (COVID-19) and, specifically, to a pharmaceutical composition containing a carbocyclic nucleoside derivative represented by chemical formula A-1 or chemical formula A-2 or a pharmaceut...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
01.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a pharmaceutical composition for prevention or treatment of coronavirus disease 19 (COVID-19) and, specifically, to a pharmaceutical composition containing a carbocyclic nucleoside derivative represented by chemical formula A-1 or chemical formula A-2 or a pharmaceutically acceptable salt thereof.
La présente invention concerne une composition pharmaceutique pour la prévention ou le traitement du coronavirus 19 (COVID-19) et, plus particulièrement, une composition pharmaceutique contenant un dérivé de nucléoside carbocyclique représenté par la formule chimique A-1 ou la formule chimique A-2 ou un sel pharmaceutiquement acceptable de celui-ci. |
---|---|
Bibliography: | Application Number: CA20223208876 |